Banner: investors

News Releases

PURE’s SDC Antimicrobial is a Featured Listeria Solution in Food Safety Consortium Presentation By James Marsden, Ph.D

November 20, 2015

Dr. Marsden Also Leads ‘Ask The Expert’ Discussion at the Summit Attended by Food Safety Industry Experts and Government Officials

 SAN DIEGO (Nov. 20, 2015) – PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the superior efficacy and safety of its SDC-based technology was highlighted as a Listeria control solution in a presentation made this week by James L. Marsden, Ph.D., Distinguished Professor – Food Safety and Security at Kansas State University,  at the Food Safety Consortium in Chicago.  

The Food Safety Consortium conference is a leading summit meeting of Food Safety and Quality Assurance industry experts and government officials.  The four-day conference drew hundreds of attendees comprised of leading industry experts, and featured prominent speakers (including the VP-Food Safety, Walmart; and the Deputy Commissioner for Foods, U.S. FDA). Conference topics included Compliance (FSMA and GFSI), Food Manufacturing Operations, Food Safety Supply Chain Management, Food Labs and Foodservice & Retail Food Safety. 

Dr. Marsden discussed the efficacy and safety of PURE’s SDC-based food safety solution technology in his presentation entitled ‘Identifying and Controlling Listeria in Food Processing Facilities.’  An ‘Ask The Expert’ discussion group session at the conference was also led by Dr. Marsden. Dr. Marsden is the author of the December 1, 2014 White Paper ‘Remediation of Listeria Contamination in a Wheeling, Illinois Food Processing Facility’ which discussed how PURE® Hard Surface (food contact surface disinfectant) was used to successfully remediate Listeria in the contaminated plant, leading to the FDA’s approval to re-open the plant for food production.

Dr. Marsden stated, “SDC’s residual kill properties provide continuous decontamination and control, which is especially important on floors, in drains and other harborage points where Listeria lives in every plant. This clearly distinguishes SDC from other chemistries in use today, and is the most important aspect of an effective Listeria control program.”  

Hank R. Lambert, Chief Executive Officer, said that, “We are proud that our SDC food safety solution technology was selected for presentation and discussion with this important and influential group of food safety experts and officials. It is further validation that our superior efficacy, environmentally friendly antimicrobial technology is a leading solution for reducing the growing risk of foodborne illness outbreaks. 

“Not only is SDC a superior solution for Listeria elimination, as discussed at the conference, but application of SDC has also achieved dramatic reductions in Salmonella, E. coli and Norovirus,” continued Lambert.

 “We look forward to greatly expanding SDC’s reach and ability to mitigate foodborne illness when we receive FDA approvals for use of PURE Control® in direct food contact applications. The FCN (food contact notification) for raw poultry processing is anticipated later in December, and the FCN for fresh produce processing is anticipated in January.  With subsequent USDA approval for raw poultry processing, we look forward to commercializing PURE Control into these combined $650 million markets by the end of calendar Q1 2016, and executing our plan to capture a significant share of these growing markets,” concluded Lambert.

About PURE Bioscience, Inc.  

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

Forward-looking Statements   

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company’s PURE Hard Surface disinfectant by SUBWAY® franchisees; the ability to convert successful evaluations into customer orders; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw poultry, produce and raw meat processing; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2015 and filed with the SEC on October 28, 2015. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.



Company Contact:

Hank Lambert, CEO
PURE Bioscience, Inc.
619-596-8600 ext.103
hlambert@purebio.com

IR Contacts:

Terri MacInnis, Director of IR
Bibicoff + MacInnis, Inc.
818-379-8500
terri@bibimac.com

Tom Hemingway
Redwood Investment Group
714-978-4425 
tomh@redwoodfin.com